Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1
Yaming Li, Yiran Liang, Yuting Sang, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K.G.K. Deepak, Rahul Kumar Vempati, Ganji Purnachandra Nagaraju, et al.
Pharmacological Research (2020) Vol. 153, pp. 104683-104683
Closed Access | Times Cited: 438
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Yuting Sang, Bing Chen, Xiaojin Song, et al.
Molecular Therapy (2019) Vol. 27, Iss. 9, pp. 1638-1652
Open Access | Times Cited: 358
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
Yiran Liang, Xiaojin Song, Yaming Li, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 340
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
Xiaoli Kong, Yi Duan, Yuting Sang, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 9105-9117
Closed Access | Times Cited: 256
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
Paola Ferrari, Cristian Scatena, Matteo Ghilli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1665-1665
Open Access | Times Cited: 104
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
Lei Ding, Huan Gu, Xianhui Xiong, et al.
Cells (2019) Vol. 8, Iss. 12, pp. 1492-1492
Open Access | Times Cited: 133
Exosomes and exosomal RNAs in breast cancer: A status update
S. Ayshwarya Lakshmi, Thomas A. Hughes, Sulochana Priya
European Journal of Cancer (2020) Vol. 144, pp. 252-268
Closed Access | Times Cited: 121
Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway
Jiguang Han, Baojuan Han, Xueya Wu, et al.
Toxicology and Applied Pharmacology (2018) Vol. 359, pp. 55-61
Closed Access | Times Cited: 117
MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer
Mohammad Mijanur Rahman, Andrew C. Brane, Trygve O. Tollefsbol
Cells (2019) Vol. 8, Iss. 10, pp. 1214-1214
Open Access | Times Cited: 99
The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer
Qingqing Liu, Fu Peng, Jianping Chen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3884-3884
Open Access | Times Cited: 95
ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
Patricia Dauer, Nikita Sharma, Vineet K. Gupta, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 2
Open Access | Times Cited: 89
Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2
Guanghui Wang, Wei Zhao, Huxia Wang, et al.
Medical Science Monitor (2019) Vol. 25, pp. 7209-7217
Open Access | Times Cited: 78
The roles of exosomes in cancer drug resistance and its therapeutic application
Shiyu Li, Ming Yi, Bing Dong, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 8
Open Access | Times Cited: 77
Tumor-derived exosomal components: the multifaceted roles and mechanisms in breast cancer metastasis
Yufang Tan, Xiao Luo, Wenchang Lv, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 68
Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity
Chao Tian, Yanyan Yang, Baochen Bai, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 5, pp. 1328-1338
Open Access | Times Cited: 60
Exosomes: A New Pathway for Cancer Drug Resistance
Yunbin Zhong, Haibo Li, Peiwen Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 59
Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies
Jun Cao, Mengdi Zhang, Bin Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 58
Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
Hongmei Zheng, Sumit Siddharth, Sheetal Parida, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3357-3357
Open Access | Times Cited: 56
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 31
Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b
Xinyu Wei, Shuang Tao, Huilan Mao, et al.
Gene (2023) Vol. 860, pp. 147230-147230
Closed Access | Times Cited: 25
Exosomal miRNAs: the tumor's trojan horse in selective metastasis
Mobina Bayat, Javid Sadri Nahand
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Potential biological roles of exosomal non‐coding RNAs in breast cancer
Li Xiang, Junyi Gong, Xiang Ni, et al.
The FASEB Journal (2025) Vol. 39, Iss. 6
Open Access | Times Cited: 1
microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy
Ranjana Kanchan, Jawed A. Siddiqui, Sidharth Mahapatra, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 62
Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19
Pengfei Zheng, Liangpeng Dong, Bin Zhang, et al.
Histochemistry and Cell Biology (2019) Vol. 152, Iss. 4, pp. 281-291
Closed Access | Times Cited: 56
Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?
Chia Yin Goh, Cathy Wyse, Matthew Ho, et al.
Cancer Letters (2020) Vol. 473, pp. 90-97
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top